Cargando…
Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing–Remitting from Secondary Progressive Multiple Sclerosis. A Review
Multiple sclerosis (MS) is a debilitating neurodegenerative, highly heterogeneous disease with a variable course. The most common MS subtype is relapsing–remitting (RR), having interchanging periods of worsening and relative stabilization. After a decade, in most RR patients, it alters into the seco...
Autores principales: | Pietrasik, Sylwia, Dziedzic, Angela, Miller, Elzbieta, Starosta, Michal, Saluk-Bijak, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584709/ https://www.ncbi.nlm.nih.gov/pubmed/34769314 http://dx.doi.org/10.3390/ijms222111887 |
Ejemplares similares
-
Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review
por: Maciak, Karina, et al.
Publicado: (2021) -
Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020) -
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020) -
Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients
por: Bijak, Michal, et al.
Publicado: (2019) -
The GPR17 Receptor—A Promising Goal for Therapy and a Potential Marker of the Neurodegenerative Process in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2020)